Merrill et al., 2019 - Google Patents
Immunological responses and evaluation of the protection in dairy cows vaccinated with staphylococcal surface proteinsMerrill et al., 2019
- Document ID
- 3500029444445038771
- Author
- Merrill C
- Ensermu D
- Abdi R
- Gillespie B
- Vaughn J
- Headrick S
- Hash K
- Walker T
- Stone E
- Dego O
- Publication year
- Publication venue
- Veterinary immunology and immunopathology
External Links
Snippet
Bovine mastitis is a significant cause of economic losses in the dairy industry. Staphylococcus aureus is one of the most common contagious mastitis pathogens, whereas Staphylococcus chromogenes increasingly became a significant cause of subclinical …
- 235000013365 dairy product 0 title abstract description 71
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01J—MANUFACTURE OF DAIRY PRODUCTS
- A01J5/00—Milking machines or devices
- A01J5/04—Milking machines or devices with pneumatic manipulation of teats
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Merrill et al. | Immunological responses and evaluation of the protection in dairy cows vaccinated with staphylococcal surface proteins | |
| Pal et al. | Public health and economic importance of bovine Brucellosis: an overview | |
| Peton et al. | Staphylococcus aureus in veterinary medicine | |
| Sears et al. | Management and treatment of staphylococcal mastitis | |
| Collado et al. | Study of the efficacy of a Streptococcus uberis mastitis vaccine against an experimental intramammary infection with a heterologous strain in dairy cows | |
| Pellegrino et al. | Experimental trial in heifers vaccinated with Staphylococcus aureus avirulent mutant against bovine mastitis | |
| Piepers et al. | Immune response after an experimental intramammary challenge with killed Staphylococcus aureus in cows and heifers vaccinated and not vaccinated with Startvac, a polyvalent mastitis vaccine | |
| Wang et al. | Research progress in live attenuated Brucella vaccine development | |
| Pellegrino et al. | Efficacy of immunization against bovine mastitis using a Staphylococcus aureus avirulent mutant vaccine | |
| Tomazi et al. | Immunization with a novel recombinant protein (YidR) reduced the risk of clinical mastitis caused by Klebsiella spp. and decreased milk losses and culling risk after Escherichia coli infections | |
| Camussone et al. | Efficacy of immunization with a recombinant S. aureus vaccine formulated with liposomes and ODN-CpG against natural S. aureus intramammary infections in heifers and cows | |
| Mella et al. | Evaluation of a new vaccine against Staphylococcus aureus mastitis in dairy herds of southern Chile. I. Challenge trial | |
| Jensen et al. | The effect of inactivated mycobacterium paratuberculosis vaccine on the response to a heterologous bacterial challenge in pigs | |
| Macedo et al. | Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response | |
| Zeng et al. | Evaluation of immunogenicity of enterobactin conjugate vaccine for the control of Escherichia coli mastitis in dairy cows | |
| US20220257743A1 (en) | Klebsiella vaccine and methods of use | |
| Zecconi | Staphylococcus aureus mastitis: what we need to know to control them | |
| Wang et al. | Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate | |
| Ster et al. | Immune and experimental infection responses of dairy cows vaccinated with the combination of six Staphylococcus aureus proteins that are expressed during bovine intramammary infection and a triple adjuvant | |
| Thongkwow et al. | Distribution and risk factors of clinical caseous lymphadenitis in small-holder goat herds in Northeastern Thailand | |
| Vidlund et al. | Efficacy of novel staphylococcal surface associated protein vaccines against Staphylococcus aureus and non-aureus staphylococcal mastitis in dairy cows | |
| Atalla et al. | Antibody and cell-mediated immune responses to Staphylococcus aureus small colony variants and their parental strains associated with bovine mastitis | |
| Kotb et al. | Evaluation of using different adjuvants used for preparation of Staphylococcus aureus mastitis vaccine on the immune response | |
| Pujato et al. | Evaluation of the humoral immune response to a multicomponent recombinant vaccine against S. aureus in healthy pregnant heifers | |
| Saeed et al. | Morel’s disease and caseous lymphadenitis: a literature review with special reference to Saudi Arabia |